David Biedermann

2.8k total citations · 1 hit paper
72 papers, 2.2k citations indexed

About

David Biedermann is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Pharmacology. According to data from OpenAlex, David Biedermann has authored 72 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Molecular Biology, 47 papers in Pulmonary and Respiratory Medicine and 21 papers in Pharmacology. Recurrent topics in David Biedermann's work include Silymarin and Mushroom Poisoning (47 papers), Synthesis and bioactivity of alkaloids (20 papers) and Berberine and alkaloids research (11 papers). David Biedermann is often cited by papers focused on Silymarin and Mushroom Poisoning (47 papers), Synthesis and bioactivity of alkaloids (20 papers) and Berberine and alkaloids research (11 papers). David Biedermann collaborates with scholars based in Czechia, United States and France. David Biedermann's co-authors include Vladimı́r Křen, Kateřina Valentová, Jan Šarek, Marián Hajdúch, Petr Džubák, Milan Urban, Miroslav Kvasnica, Lenka Marková, David Vydra and Ladislav Cvak and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and The Journal of Physical Chemistry B.

In The Last Decade

David Biedermann

71 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pharmacological activities of natural triterpenoids and their therapeutic implications

2006 584 citations David Biedermann et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Biedermann Czechia	24	1.4k	897	495	411	268	72	2.2k
Daniela Walterová Czechia	22	1.1k 0.8×	1.2k 1.4×	731 1.5×	610 1.5×	280 1.0×	35	3.0k
Radek Gažák Czechia	22	1.0k 0.7×	1.1k 1.2×	640 1.3×	347 0.8×	76 0.3×	41	1.8k
Jitka Psotová Czechia	18	663 0.5×	337 0.4×	245 0.5×	199 0.5×	232 0.9×	21	1.6k
Kateřina Valentová Czechia	32	1.3k 1.0×	641 0.7×	449 0.9×	463 1.1×	627 2.3×	95	3.5k
Lie-Chwen Lin Taiwan	30	1.1k 0.8×	301 0.3×	560 1.1×	670 1.6×	468 1.7×	70	2.9k
Jiřı́ Vrba Czechia	23	644 0.5×	175 0.2×	338 0.7×	280 0.7×	202 0.8×	51	1.4k
Mitsuo Miyazawa Japan	31	1.2k 0.9×	295 0.3×	630 1.3×	398 1.0×	1.2k 4.4×	217	3.5k
Sattu Kamaraj India	25	786 0.6×	144 0.2×	167 0.3×	256 0.6×	234 0.9×	43	1.8k
Kuntal Maiti India	18	471 0.3×	202 0.2×	152 0.3×	390 0.9×	364 1.4×	25	1.9k
Barbara Simi United States	32	1.4k 1.0×	123 0.1×	898 1.8×	185 0.5×	263 1.0×	39	3.8k

Countries citing papers authored by David Biedermann

Since Specialization

Citations

This map shows the geographic impact of David Biedermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Biedermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Biedermann more than expected).

Fields of papers citing papers by David Biedermann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Biedermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Biedermann. The network helps show where David Biedermann may publish in the future.

Co-authorship network of co-authors of David Biedermann

This figure shows the co-authorship network connecting the top 25 collaborators of David Biedermann. A scholar is included among the top collaborators of David Biedermann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Biedermann. David Biedermann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hoàng, Lan, David Biedermann, Marek Kuzma, et al.. (2022). Selectively Halogenated Flavonolignans—Preparation and Antibacterial Activity. International Journal of Molecular Sciences. 23(23). 15121–15121. 16 indexed citations

Hrubša, Marcel, Eduard Jirkovský, David Biedermann, et al.. (2021). Silymarin Dehydroflavonolignans Chelate Zinc and Partially Inhibit Alcohol Dehydrogenase. Nutrients. 13(12). 4238–4238. 10 indexed citations

Franková, Jana, et al.. (2021). Influence of silymarin components on keratinocytes and 3D reconstructed epidermis. Toxicology in Vitro. 74. 105162–105162. 7 indexed citations

Řehořová, Kateřina, David Biedermann, Lucie Petrásková, et al.. (2020). Multidrug Resistance Modulation Activity of Silybin Derivatives and Their Anti-Inflammatory Potential. Antioxidants. 9(5). 455–455. 43 indexed citations

Hrčková, Gabriela, et al.. (2020). Co-administration of silymarin elevates the therapeutic effect of praziquantel through modulation of specific antibody profiles, Th1/Th2/Tregs cytokines and down-regulation of fibrogenesis in mice with Mesocestoides vogae (Cestoda) infection. Experimental Parasitology. 213. 107888–107888. 6 indexed citations

Pourová, Jana, Lenka Applová, Kateřina Macáková, et al.. (2019). The Effect of Silymarin Flavonolignans and Their Sulfated Conjugates on Platelet Aggregation and Blood Vessels Ex Vivo. Nutrients. 11(10). 2286–2286. 18 indexed citations

Viktorová, Jitka, Kateřina Řehořová, David Biedermann, et al.. (2019). Antioxidant, Anti-Inflammatory, and Multidrug Resistance Modulation Activity of Silychristin Derivatives. Antioxidants. 8(8). 303–303. 27 indexed citations

Svobodová, Alena Rajnochová, et al.. (2019). A pilot study of the UVA-photoprotective potential of dehydrosilybin, isosilybin, silychristin, and silydianin on human dermal fibroblasts. Archives of Dermatological Research. 311(6). 477–490. 20 indexed citations

Sheehan, Alice, Andrew E. Messer, Maria Papadaki, et al.. (2018). Molecular Defects in Cardiac Myofilament Ca2+-Regulation Due to Cardiomyopathy-Linked Mutations Can Be Reversed by Small Molecules Binding to Troponin. Frontiers in Physiology. 9. 243–243. 19 indexed citations

10.

Catapano, Maria Carmen, Jana Karlíčková, David Biedermann, et al.. (2018). Interaction of isolated silymarin flavonolignans with iron and copper. Journal of Inorganic Biochemistry. 189. 115–123. 11 indexed citations

11.

Kosina, Pavel, Markéta Paloncýová, Alena Rajnochová Svobodová, et al.. (2018). Dermal Delivery of Selected Polyphenols from Silybum marianum. Theoretical and Experimental Study. Molecules. 24(1). 61–61. 18 indexed citations

12.

Dinkova‐Kostova, Albena T., et al.. (2017). Flavonolignan 2,3-dehydrosilydianin activates Nrf2 and upregulates NAD(P)H:quinone oxidoreductase 1 in Hepa1c1c7 cells. Fitoterapia. 119. 115–120. 32 indexed citations

13.

Huang, Guozheng, et al.. (2016). Unconventional application of the Mitsunobu reaction: Selective flavonolignan dehydration yielding hydnocarpins. Beilstein Journal of Organic Chemistry. 12. 662–669. 10 indexed citations

14.

Biedermann, David, Barbora Papoušková, Jan Vacek, et al.. (2016). Semisynthetic flavonoid 7-O-galloylquercetin activates Nrf2 and induces Nrf2-dependent gene expression in RAW264.7 and Hepa1c1c7 cells. Chemico-Biological Interactions. 260. 58–66. 12 indexed citations

15.

Papaevgeniou, Nikoletta, et al.. (2016). 2,3-Dehydrosilybin A/B as a pro-longevity and anti-aggregation compound. Free Radical Biology and Medicine. 103. 256–267. 33 indexed citations

16.

Vavříková, Eva, Kateřina Purchartová, David Biedermann, et al.. (2015). Regioselective Alcoholysis of Silychristin Acetates Catalyzed by Lipases. International Journal of Molecular Sciences. 16(6). 11983–11995. 6 indexed citations

17.

Biler, Michal, David Biedermann, Kateřina Valentová, et al.. (2015). Flavonolignan 2,3-dehydroderivatives: Preparation, antiradical and cytoprotective activity. Free Radical Biology and Medicine. 90. 114–125. 75 indexed citations

18.

Deep, Gagan, Chapla Agarwal, Michael F. Wempe, et al.. (2014). Silibinin and its 2,3‐dehydro‐derivative inhibit basal cell carcinoma growth via suppression of mitogenic signaling and transcription factors activation. Molecular Carcinogenesis. 55(1). 3–14. 33 indexed citations

19.

Gažák, Radek, David Biedermann, Florent Di Meo, et al.. (2014). cis–trans Isomerization of silybins A and B. Beilstein Journal of Organic Chemistry. 10. 1047–1063. 14 indexed citations

20.

Zorich, Nora L., et al.. (1997). Randomized, Double-Blind, Placebo-Controlled, Consumer Rechallenge Test of Olean Salted Snacks. Regulatory Toxicology and Pharmacology. 26(2). 200–209. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact